BRIEF-Rohto Pharmaceutical Co Ltd Acquisition Of Shares In And Tender Offer For EU Yan Sang International Ltd, A Singapore Health And Wellness Manufacturing And Sales Company
Rohto Pharmaceutical Co Ltd:
* ROHTO PHARMACEUTICAL CO LTD: ACQUISITION OF SHARES IN AND TENDER OFFER FOR EU YAN SANG INTERNATIONAL LTD, A SINGAPORE HEALTH AND WELLNESS MANUFACTURING AND SALES COMPANY
* ROHTO PHARMACEUTICAL CO LTD: TO JOINTLY ACQUIRE APPROXIMATELY 86% OF ISSUED ORDINARY SHARES OF EU YAN SANG INTERNATIONAL LTD WITH MITSUI & CO
* ROHTO PHARMACEUTICAL CO LTD: UPON FULFILLMENT OF CONDITION TO SHARE ACQUISITION, WE WILL CONDUCT A MANDATORY GENERAL OFFER FOR REMAINING 14% OF ISSUED ORDINARY SHARES OF EYS
* ROHTO PHARMACEUTICAL CO LTD: VALUE ATTRIBUTED TO 100% OF SHARES OF EYS IS APPROXIMATELY 800 MILLION SINGAPORE DOLLARS
* ROHTO PHARMACEUTICAL CO LTD: AFTER THE TENDER OFFER , MITSUI & CO. IS EXPECTED TO HOLD ABOUT 30% EFFECTIVE INTEREST IN EYS, WITH ROHTO HOLDING ABOUT 60%, AND FOUNDING FAMILY REINVESTING IN SPC AS PART OF MANAGEMENT RETENTION ARRANGEMENTS AND HOLDING ABOUT 10% Source text for Eikon: Further company coverage: